Arcutis Biotherapeutics Inc (NAS:ARQT)
$ 24.78 -0.58 (-2.29%) Market Cap: 3.11 Bil Enterprise Value: 2.99 Bil PE Ratio: 120.29 PB Ratio: 14.08 GF Score: 56/100

Arcutis Biotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 05, 2026 / 02:30PM GMT
Release Date Price: $21.23 (-3.28%)
Frank Watanabe
Arcutis Biotherapeutics Inc - President and Chief Executive Officer

Good morning, ladies and gentlemen. It's my pleasure to welcome you to the 2026 Annual Meeting of Stockholders of Arcutis Biotherapeutics, Inc. I'm Frank Watanabe, the President and Chief Executive Officer of Arcutis.

In accordance with our bylaws, I will act as the Chairperson of this meeting. [John Holway] from Broadridge Financial Solutions is with us today and will act as Inspector of Election. I have been advised by our Inspector of Election that 86.46% of the shares of common stock are represented virtually or by proxy and that a quorum is present. The meeting is now called to order, and we will follow the rules of conduct and order of business of the meeting as listed in the program posted on the virtual meeting website.

Before we begin with the formalities of the Annual Meeting, I would like to introduce to you other team members who have joined me for the meeting. Latha Vairavan, our Chief Financial Officer; Mas Matsuda, our Chief Legal Officer and Corporate Secretary of this meeting; and Brian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot